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Background and Purpose
Intensity modulated radiation therapy (IMRT) is an 
established technique for the treatment of prostate 
cancer. Volumetric modulated arc therapy (VMAT)  
has recently been introduced clinically. Nucletron BV 
(Veenendal, Netherlands) offers both optimisation 
algorithms on the same platform in Oncentra® 
MasterPlan 3.3. 
They are compared regarding dose distribution and 
treatment time.
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Material and Methods
• 5 patients with localised prostate cancer





• Linac: Elekta SynergyS with Beam Modulator
• Planning system: Oncentra MasterPlan, Nucletron




7 fields, equispaced, 
0°, 51°, 103°, 154°, 
206°, 257°, 308°
a)Dual arc, 182°-




PTV min 68 Gy, 3000
PTV max 72 Gy, 3000
Urinary bladder 40 Gy, 50%, 1000
Rectum, 40 Gy, 30%, 1000
Femoral heads, max 30 Gy, 300
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Results




Rectum vol. 30% 44.7 Gy 46.1 Gy 45.4 Gy
Bladder vol. 50% 44.1 Gy 43.3 Gy 40.4 Gy
Fem. Heads max. 32.1 Gy 34.1 Gy 31.7 Gy
Average MU 698 1016 794
Treatment time
(one case)
10.14min/775 MU 8.09min/1088 MU 4.50min/845 MU
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Conclusion
The results of the dose distribution are similar 
enough that VMAT is an interesting alternative to 
IMRT for the treatment of prostate cancer. The 
treatment time, which is the crucial factor regarding 
intrafractional organ movements is advantageous for 
both VMAT techniques, but again shorter for single 
arc with comparable plan quality.
